These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 33328393

  • 1. Half depletion of Foxp3+ regulatory T cells by diphtheria toxin for long-term study in vivo.
    Qiu X, Leung WT, Gober HJ, Li L, Zhang N, Chu N, Wang L.
    Biosci Trends; 2021 Jan 23; 14(6):460-462. PubMed ID: 33328393
    [Abstract] [Full Text] [Related]

  • 2. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
    Christiaansen AF, Boggiatto PM, Varga SM.
    J Immunol Methods; 2014 Apr 23; 406():58-65. PubMed ID: 24642426
    [Abstract] [Full Text] [Related]

  • 3. Depletion of Treg by the Diphtheria Toxin System.
    Hanakawa S, Chow Z, Kabashima K.
    Methods Mol Biol; 2023 Apr 23; 2559():31-39. PubMed ID: 36180624
    [Abstract] [Full Text] [Related]

  • 4. Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response.
    Wang J, Siffert M, Spiliotis M, Gottstein B.
    J Immunol Res; 2016 Apr 23; 2016():1450398. PubMed ID: 28074191
    [Abstract] [Full Text] [Related]

  • 5. Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.
    Chenna Narendra S, Chalise JP, Biggs S, Kalinke U, Magnusson M.
    Front Immunol; 2018 Apr 23; 9():285. PubMed ID: 29515584
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant effect of diphtheria toxin after mucosal administration in both wild type and diphtheria toxin receptor engineered mouse strains.
    Chapman TJ, Georas SN.
    J Immunol Methods; 2013 Dec 31; 400-401():122-6. PubMed ID: 24200744
    [Abstract] [Full Text] [Related]

  • 7. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S, Sagiv Y, Kaminitz A, Farkas DL, Askenasy N.
    Eur J Immunol; 2009 Oct 31; 39(10):2850-64. PubMed ID: 19735074
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
    Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, Garbi N, Hämmerling GJ.
    J Immunol; 2010 Feb 15; 184(4):1810-20. PubMed ID: 20083650
    [Abstract] [Full Text] [Related]

  • 9. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury.
    Lees JG, Duffy SS, Perera CJ, Moalem-Taylor G.
    Cytokine; 2015 Feb 15; 71(2):207-14. PubMed ID: 25461400
    [Abstract] [Full Text] [Related]

  • 10. Treg depletion in non-human primates using a novel diphtheria toxin-based anti-human CCR4 immunotoxin.
    Wang Z, Pratts SG, Zhang H, Spencer PJ, Yu R, Tonsho M, Shah JA, Tanabe T, Powell HR, Huang CA, Madsen JC, Sachs DH, Wang Z.
    Mol Oncol; 2016 Apr 15; 10(4):553-65. PubMed ID: 26643572
    [Abstract] [Full Text] [Related]

  • 11. Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin.
    Wang Z, Navarro-Alvarez N, Shah JA, Zhang H, Huang Q, Zheng Q, Madsen JC, Sachs DH, Huang CA, Wang Z.
    Vet Immunol Immunopathol; 2016 Dec 15; 182():150-158. PubMed ID: 27863545
    [Abstract] [Full Text] [Related]

  • 12. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice.
    Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, deRoos P, Rudensky A, Sparwasser T.
    J Immunol; 2009 Dec 15; 183(12):7631-4. PubMed ID: 19923467
    [Abstract] [Full Text] [Related]

  • 13. In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.
    Lahl K, Sparwasser T.
    Methods Mol Biol; 2011 Dec 15; 707():157-72. PubMed ID: 21287334
    [Abstract] [Full Text] [Related]

  • 14. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
    Klingenberg R, Gerdes N, Badeau RM, Gisterå A, Strodthoff D, Ketelhuth DF, Lundberg AM, Rudling M, Nilsson SK, Olivecrona G, Zoller S, Lohmann C, Lüscher TF, Jauhiainen M, Sparwasser T, Hansson GK.
    J Clin Invest; 2013 Mar 15; 123(3):1323-34. PubMed ID: 23426179
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3+ Tregs.
    Chen X, Berin MC, Gillespie VL, Sampson HA, Dunkin D.
    Front Immunol; 2021 Mar 15; 12():637630. PubMed ID: 33717186
    [Abstract] [Full Text] [Related]

  • 16. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T.
    Cancer Res; 2010 Oct 15; 70(20):7788-99. PubMed ID: 20924102
    [Abstract] [Full Text] [Related]

  • 17. Depletion of Foxp3+ regulatory T cells but not the absence of CD19+IL-10+ regulatory B cells hinders tumor growth in a para-orthotopic neuroblastoma mouse model.
    Weißenborn C, von Lenthe S, Hinz N, Langwisch S, Busse M, Schumacher A, Zenclussen AC, Fest S.
    Int J Cancer; 2022 Dec 01; 151(11):2031-2042. PubMed ID: 36054664
    [Abstract] [Full Text] [Related]

  • 18. Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.
    Gyori D, Lim EL, Grant FM, Spensberger D, Roychoudhuri R, Shuttleworth SJ, Okkenhaug K, Stephens LR, Hawkins PT.
    JCI Insight; 2018 Jun 07; 3(11):. PubMed ID: 29875321
    [Abstract] [Full Text] [Related]

  • 19. Diphtheria toxin-based recombinant murine IL-2 fusion toxin for depleting murine regulatory T cells in vivo.
    Wei M, Marino J, Trowell A, Zhang H, Stromp Peraino J, Rajasekera PV, Madsen JC, Sachs DH, Huang CA, Benichou G, Wang Z.
    Protein Eng Des Sel; 2014 Sep 07; 27(9):289-95. PubMed ID: 25147093
    [Abstract] [Full Text] [Related]

  • 20. Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
    Kohno M, Murakami J, Wu L, Chan ML, Yun Z, Cho BCJ, de Perrot M.
    J Immunol; 2020 Nov 01; 205(9):2519-2531. PubMed ID: 32948683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.